Business Canada House brings in $4M in revenue, cuts losses in half A loss of $2.6M this quarter represents a 58% drop Kathryn TindaleSeptember 29, 2021
Business InMed Pharmaceuticals reports net loss of US$10.2M The firm says expenses will increase as research and 'important progress' continues Kathryn TindaleSeptember 24, 2021
Business Avicanna files patent for cannabinoid med that reduces epileptic seizures, sudden death A number of the medical cannabis maker's products are available to Canadian patients Natalia Buendia CalvilloSeptember 24, 2021
Canada Medical cannabis training for Sobeys pharmacists expands in Maritimes Pathway Health is helping pharmacies prepare in anticipation of changes to Canada's pot laws Kathryn TindaleSeptember 23, 2021
Health and Safety US CDC and FDA issue warnings on delta-8 THC The agencies are trying to crack down on the alternative cannabinoid after a surge in availability and adverse events this year Natalia Buendia CalvilloSeptember 17, 2021
Health and Safety Scottish MPs set up cross-party medical cannabis group The Cross-Party Group on Medical Cannabis hopes to shed light on developing treatments Kathryn TindaleSeptember 16, 2021
Canada Study on increased post-legalization cannabis ICU visits in youth ‘misleading’ The research relied on an inaccurate timeframe and didn't distinguish between legal and illegal products, critics say Natalia Buendia CalvilloSeptember 14, 2021
Business Mature US state medical cannabis markets stabilize at 10–20% of total sales: Headset Recreational sales make up the bulk of transactions, but patients stick to the medical system for a number of reasons Nick LabaSeptember 14, 2021
Business Valens accesses GMP facility through Australian partnership The five-year deal allows the company to access 85% operational capacity of a Queensland facility Kathryn TindaleSeptember 8, 2021
Cannabis US DEA suggests big increase of cannabis and psilocybin production for research The agency says it supports research into the substances and it's necessary for the FDA to approve new quotas Kathryn TindaleSeptember 1, 2021